Drug due to be rejected by NICE for use on the NHS for MS Published: 21 December 2021 Famprya (fampridine) is set to be rejected by The National Institute for Health and Care Excellence (NICE) in England for use on the NHS for people with multiple sclerosis (MS). NICE will